Trial · NCT03718338
Mechanisms of Metabolic and Hormone Action on Plaque Formation in Brain and Carotid Vessels in Patients With Prostate Adenocarcinoma
NCT03718338, Terminated, University of Washington
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Mechanisms of Metabolic and Hormone Action on Plaque Formation in Brain and Carotid Vessels in Patients With Prostate Adenocarcinoma. Trials, record NCT03718338. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03718338
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Mechanisms of Metabolic and Hormone Action on Plaque Formation in Brain and Carotid Vessels in Patients With Prostate Adenocarcinoma
- NCT number
- NCT03718338
- Status
- Terminated
- Enrollment
- 2 participants, actual
- Lead sponsor
- University of Washington
- Conditions
- Prostate Adenocarcinoma
- Interventions
- Evaluation, Quality-of-Life Assessment
- First posted
- 2018-10-24
- Last updated
- 2020-12-10
Source ClinicalTrials.gov
Registered outcomes22
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in visual characterization of 18F-florbetapir (Amyvid) positron emission tomography (PET) scans results after Andorgen Deprivation Therapy | 12 Months | Change From Baseline visual characterization scan results at 12 months |
| Primary | Change standardized uptake values of 18F-florbetapir (Amyvid) positron emission tomography (PET) scans results | 12 Months | Change from baseline standardized uptake values in select regions of interest at 12 months |
| Secondary | Cognitive test results: Story recall | 12 months | Change in baseline Story Recall results at 12 months |
| Secondary | Cognitive Test Results: Change in Montreal Cognitive Assessment (MOCA) | 12 Months | Change in baseline MOCA score results at 12 months |
| Secondary | Cognitive Test Results: Change in Clinical Dementia Rating Scale | 12 Months | Change in baseline Clinical Dementia Rating Scale score at 12 months |
| Secondary | Cognitive Test Results: Digit span | 12 Months | Change in baseline Digit span results at 12 months |
| Secondary | Cognitive Test Results: Letter number sequencing | 12 Months | Change in baseline Letter number sequencing results at 12 months |
| Secondary | Cognitive Test Results: Stroop Test Results | 12 Months | Change in baseline Stroop Test Results at 12 months |
| Secondary | Cognitive Test Results: Symbol Digit Modalities Test | 12 Months | Change in baseline Symbol Digit Modalities Test score at 12 months |
| Secondary | Cognitive Test Results: Visuo-Spatial Learning Test | 12 Months | Change in baseline Visuo-Spatial Learning Test results at 12 months |
1 to 10 of 22Source ClinicalTrials.gov
See all 22 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| P30CA015704 | Cancer Center Support Grant | LYNCH, THOMAS JAMES | FRED HUTCHINSON CANCER CENTER | NATIONAL CANCER INSTITUTE | 1985 to 2025 |
Source NIH RePORTER
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests6
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Digit Span Test | Secondary outcome | ConductCognition |
| Letter-Number Sequencing Task | Secondary outcome | ConductCognition |
| Short Story Recall | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Symbol Coding | Secondary outcome | ConductCognition |
| Verbal Learning | Secondary outcome | ConductCognition |
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03718338
GET https://conductscience.org/api/trials/v1/NCT03718338/registered?page=2